Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Constellation Brands
STZ
US Stock MarketDetailed Quotes
NRIX Nurix Therapeutics
- 11.360
- -0.200-1.73%
Trading Apr 28 11:41 ET
866.04MMarket Cap-4.07P/E (TTM)
11.720High11.325Low120.66KVolume11.620Open11.560Pre Close1.39MTurnover0.20%Turnover RatioLossP/E (Static)76.24MShares29.56052wk High1.80P/B671.63MFloat Cap8.18052wk Low--Dividend TTM59.12MShs Float52.380Historical High--Div YieldTTM3.42%Amplitude4.220Historical Low11.555Avg Price1Lot Size
About Nurix Therapeutics Company
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Company Profile
SymbolNRIX
Company NameNurix Therapeutics
Listing DateJul 24, 2020
Issue Price19.00
Founded2009
CEODr. Arthur T. Sands, M.D.,PhD
MarketNASDAQ
Employees286
Fiscal Year Ends11-30
Address1700 Owens Street,Suite 205
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-660-5320
Websitehttp://www.nurixtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Arthur T. Sands, M.D.,PhD
- Director, President and Chief Executive Officer
- 5.81M
- Hans van Houte
- Chief Financial Officer and Principal Accounting Officer
- 2.02M
- Dr. Gwenn Hansen, PhD
- Chief Scientific Officer
- 2.03M
- Dr. Christine Ring, J.D.,PhD
- Chief Legal Officer, Chief Compliance Officer and Secretary
- 2.02M
- Julia P. Gregory
- Chairman of the Board
- 371.62K
- Dr. Roy D. Baynes, M.D.,PhD
- Director
- --
- Judith A. Reinsdorf, J.D.
- Independent Director
- 342.01K
- Paul M. Silva
- Independent Director
- 338.68K
- Edward C. Saltzman
- Independent Director
- 336.18K
- Anil Kapur
- Independent Director
- 821.99K
- Dr. Lori Anne Kunkel, M.D.
- Independent Director
- 341.18K
- Dr. David L. Lacey, M.D.
- Independent Director
- 355.76K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
